Medicine News and Research

RSS

Study provides insight into why older adults are so vulnerable to pneumonia

A study featured on the cover of the March 15 Journal of Immunology is providing insight into why the elderly are so vulnerable to pneumonia and other bacterial infections.

15 Mar 2011

Smoking cessation prior surgery not linked to increased risk of postoperative complications

A meta-analysis of nine previous studies found that quitting smoking shortly before surgery was not associated with an increased risk of postoperative complications, according to a report published online today that will appear in the July 11 print issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

15 Mar 2011

New UCSD center investigates link between Alzheimer's and Down syndrome

A new center combining academic research with the treatment of adults with Down syndrome - one of the first in the country - has opened at the University of California, San Diego School of Medicine.

15 Mar 2011

Study evaluates potential national savings from discount generic medication programs

If all eligible patients filled their prescriptions through a $4 generic drug program, the societal savings could amount to nearly $6 billion, according to a University of Pittsburgh Graduate School of Public Health study.

15 Mar 2011

Heavy alcohol consumption linked to increased risk of death from pancreatic cancer

Heavy alcohol consumption, specifically three or more glasses of liquor a day, is associated with an increased risk of death from pancreatic cancer, according to a report in the March 14 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

15 Mar 2011

Older people who receive Guided Care use fewer expensive health services

A new report shows that older people who receive Guided Care, a new form of primary care, use fewer expensive health services compared to older people who receive regular primary care.

15 Mar 2011

Cancer Research UK introduces new centre in Oxford

A new centre launched today will cement Oxford's place at the forefront of cancer research, and form one of the final links in a unique chain of Cancer Research UK Centres across the country.

15 Mar 2011

Scientists identify strategy for targeted molecular therapy in liver cancer

In a research study appearing in the journal Cancer Cell on March 14, scientists from Cold Spring Harbor Laboratory and four other institutions have identified a strategy for targeted molecular therapy in liver cancer, which currently has limited treatment options and one of the worst one-year survival rates of any cancer type.

15 Mar 2011

New findings may open doors for vaccine development against HIV, tuberculosis

Alum is an adjuvant used in many common vaccines, and Canadian researchers have now discovered how it works. The research by scientists from the University of Calgary's Faculty of Medicine is published in the March 13 online edition of Nature Medicine.

15 Mar 2011

Study: Statin use may reduce risk of high-grade prostate cancer

Men who take a certain class of cholesterol-lowering medicine, otherwise known as statins, may be 60 percent less likely to be diagnosed with high-grade prostate cancer.

15 Mar 2011

New research may shed light on possible treatments for prion diseases

New research by Chongsuk Ryou, researcher at the UK Sanders-Brown Center on Aging and professor of microbiology, immunology and molecular genetics in the UK College of Medicine, may shed light on possible treatments for prion diseases.

15 Mar 2011

Dog owners more physically active: proven many times over now

There is enough scientific evidence now to show that dogs can be powerful motivators to get people moving. Dog owners are more likely to take regular walks and new research has shown that dog walkers are more active overall than people who don’t have dogs. One of the studies showed that older people are more likely to take regular walks if the walking companion is canine rather than human.

14 Mar 2011

Bad jobs can make one mentally ill: Study

A latest study shows that a job that provides low control, high demands, complexity and the perception of unfair pay may lead to worse mental health than being unemployed. The study appeared in the journal Occupational Environmental Medicine.

14 Mar 2011

Repligen reports positive results from RG1068 Phase 3 study to improve MRI of the pancreas

Repligen Corporation reported today positive top-line results from a Phase 3 study to evaluate the safety and efficacy of RG1068, synthetic human secretin, to improve magnetic resonance imaging (MRI) of the pancreas in patients with pancreatic disease using endoscopy (ERCP) as a diagnostic reference.

14 Mar 2011

Bonding with mom develops over first few weeks of life in rodent pups

For rodent pups, bonding with mom isn't hard-wired in the womb. It develops over the first few weeks of life, which is achieved by their maturing sense of smell, possibly allowing these mammals a survival advantage by learning to identify mother, siblings, and home.

14 Mar 2011

How male puberty begins

Scientists from Monash University have uncovered a new understanding of how male puberty begins.

14 Mar 2011

Study provides insight into aging immune system

A study featured on the cover of the March 15 Journal of Immunology is providing insight into why the elderly are so vulnerable to pneumonia and other bacterial infections.

14 Mar 2011

LA Times: Q & A with Surgeon General Regina Benjamin

U.S. Surgeon General Dr. Regina M. Benjamin wants to make America healthier, one community at a time.

14 Mar 2011

Transcept initiates enrollment in TO-2061 Phase 2 study for treatment resistant obsessive compulsive disorder

Transcept Pharmaceuticals, Inc. today announced the first patient has been enrolled in a Phase 2 clinical study to evaluate TO-2061 as an adjunctive treatment for obsessive compulsive disorder (OCD) in patients who have responded inadequately to currently approved treatments. OCD affects 1 to 2 percent of the United States adult population and can significantly impair the lives of patients and their families.

14 Mar 2011

Omthera commences dosing in pivotal Epanova Phase III EVOLVE trial in patients with very high triglycerides

Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that the first patient has been dosed in its pivotal Phase III EVOLVE (EpanoVa fOr Lowering Very high triglyceridEs) trial for Epanova™, the Company's lead compound for the treatment of patients with very high triglycerides. Epanova is an Omega-3 fatty acid containing a novel formulation of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).

14 Mar 2011